MapLight Therapeutics, Inc. Financial Overview
MapLight Therapeutics, Inc.'s market cap is currently $810.36M. The company's EPS TTM is $; its P/E ratio is ―; MapLight Therapeutics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.